Aussie8 – Lifestyle
Author:
Sionna Therapeutics, Inc.
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
May 13, 2026
Sionna Therapeutics Reports First Quarter 2026 Financial Results
May 12, 2026
Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis
April 27, 2026
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
April 7, 2026